Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1 (A) Chest computed tomography scans of the patient

Published byBenedict Johnston Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 1 (A) Chest computed tomography scans of the patient"— Presentation transcript:

1 Figure 1 (A) Chest computed tomography scans of the patient
Figure 1 (A) Chest computed tomography scans of the patient. Flow cytometric analysis of lymphocyte subsets in the right pleural fluid of the patient. (B) Expression of CD19 and CD3 on CD45<sup>+</sup> cells. (C) Expression of CD4 and CD8 on CD3<sup>+</sup> T cells. Flow cytometric analysis of immune-checkpoint proteins expressed on the surface of T cells in pleural effusion of the patient and two cases of lung cancer. Expression of PD-1 and TIM-3 on CD8<sup>+</sup> T cells and CD4<sup>+</sup> T cells in pleural effusion was examined for the present patient (D) as well as for patients with lung cancer whose disease progressed during treatment with erlotinib (E) or osimertinib (F). From: Tumor-infiltrating lymphocyte-mediated pleuritis followed by marked shrinkage of metastatic kidney cancer of the chest wall during nivolumab treatment Ann Oncol. 2017;28(8): doi: /annonc/mdx214 Ann Oncol | © The Author Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please

Download ppt "Figure 1 (A) Chest computed tomography scans of the patient"

Similar presentations

How to manage suspected cancer

How to manage suspected cancer
From: An open day in the metric space

From: An open day in the metric space
Fig. 3. Plot of overall survival by adjuvant therapy for patient subgroups. (A) Patients with M0 disease (n = 411). (B) Patients receiving 36 Gy craniospinal.

Fig. 3. Plot of overall survival by adjuvant therapy for patient subgroups. (A) Patients with M0 disease (n = 411). (B) Patients receiving 36 Gy craniospinal.
Figure 1 WBC count (A), platelet count (B), MPV (C), platelet activation rate (D) and TGF-β1concentration (E) in the PF of women with endometriosis and.

Figure 1 WBC count (A), platelet count (B), MPV (C), platelet activation rate (D) and TGF-β1concentration (E) in the PF of women with endometriosis and.
Fig. 1 Flow chart of the COBRA-light trial and its extension study

Fig. 1 Flow chart of the COBRA-light trial and its extension study
From: Global Banking: Recent Developments and Insights from Research*

From: Global Banking: Recent Developments and Insights from Research*
Figure 2. Quality of life (QOL) scores for functional scale items

Figure 2. Quality of life (QOL) scores for functional scale items
Figure 1. FinHER dataset: distribution of tumor-infiltrating lymphocytes in breast cancer according to the (A) three breast cancer subtypes and (B) HER2.

Figure 1. FinHER dataset: distribution of tumor-infiltrating lymphocytes in breast cancer according to the (A) three breast cancer subtypes and (B) HER2.
Figure 1. Dose modification scheme for the second cycle of capecitabine treatment. From: Adjuvant capecitabine chemotherapy using a tailored-dose strategy.

Figure 1. Dose modification scheme for the second cycle of capecitabine treatment. From: Adjuvant capecitabine chemotherapy using a tailored-dose strategy.
Figure 1. Scree plot for the exploratory factor analysis (EFA) of the Death Depression Scale (DDS). From: Development and psychometric evaluation of a.

Figure 1. Scree plot for the exploratory factor analysis (EFA) of the Death Depression Scale (DDS). From: Development and psychometric evaluation of a.
Figure 2. CONSORT flow diagram.

Figure 2. CONSORT flow diagram.
Figure 1 (A) Chest x-ray (posteroanterior view) showed a cavitary lesion with an air-fluid level in the right upper lobe. (B) Computed tomography of the.

Figure 1 (A) Chest x-ray (posteroanterior view) showed a cavitary lesion with an air-fluid level in the right upper lobe. (B) Computed tomography of the.
Fig. 1 GBM TIMs expand to inhibit vaccine-induced T-cell mediated tumor cytolysis via PD-1/PD-L1 regulatory pathway. (A, D) CD163, DAPI, (B, E) PD-L1,

Fig. 1 GBM TIMs expand to inhibit vaccine-induced T-cell mediated tumor cytolysis via PD-1/PD-L1 regulatory pathway. (A, D) CD163, DAPI, (B, E) PD-L1,
pSS: primary SS; Scl: scleroderma.

pSS: primary SS; Scl: scleroderma.
Figure 3. Examples of tweets classified as ridicule.

Figure 3. Examples of tweets classified as ridicule.
Figure 2: The Medical Imaging Projection System projecting the real-time fluorescent image on the surface of the lung during surgery (left). The cut surface.

Figure 2: The Medical Imaging Projection System projecting the real-time fluorescent image on the surface of the lung during surgery (left). The cut surface.
Figure 1. Selection of papers.

Figure 1. Selection of papers.
Fig. 1 Flow chart of study selection

Fig. 1 Flow chart of study selection
Figure 1. Conceptual model of well-being related to involvement in theatre. From: Theatre Involvement and Well-Being, Age Differences, and Lessons From.

Figure 1. Conceptual model of well-being related to involvement in theatre. From: Theatre Involvement and Well-Being, Age Differences, and Lessons From.
Figure 1. (A) Forest plot of common odds ratios (adjusted for ECOG PS) for best overall response by a priori subgroups in patients with KRAS wild-type.

Figure 1. (A) Forest plot of common odds ratios (adjusted for ECOG PS) for best overall response by a priori subgroups in patients with KRAS wild-type.

Similar presentations

Ads by Google